Tai Sandi See - 19 Feb 2025 Form 4 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Chief Development Officer
Signature
/s/ Youjin Choi, Attorney-in-Fact
Issuer symbol
LXEO
Transactions as of
19 Feb 2025
Net transactions value
-$6,558
Form type
4
Filing time
21 Feb 2025, 17:09:42 UTC
Previous filing
10 Jan 2025
Next filing
09 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXEO Common Stock Sale $6,558 -1,486 -2.7% $4.41 53,889 19 Feb 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
F2 Includes 51,218 RSUs.